Global Oncology & Cancer Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 151
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Oncology & Cancer Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified. When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Oncology & Cancer Drugs industry chain, the market status of Blood Cancer (Chemotherapy, Targeted Therapy), Breast Cancer (Chemotherapy, Targeted Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oncology & Cancer Drugs.
Regionally, the report analyzes the Oncology & Cancer Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oncology & Cancer Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oncology & Cancer Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oncology & Cancer Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Chemotherapy, Targeted Therapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oncology & Cancer Drugs market.
Regional Analysis: The report involves examining the Oncology & Cancer Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oncology & Cancer Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oncology & Cancer Drugs:
Company Analysis: Report covers individual Oncology & Cancer Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oncology & Cancer Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Blood Cancer, Breast Cancer).
Technology Analysis: Report covers specific technologies relevant to Oncology & Cancer Drugs. It assesses the current state, advancements, and potential future developments in Oncology & Cancer Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oncology & Cancer Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oncology & Cancer Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
Market segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Others
Major players covered
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oncology & Cancer Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oncology & Cancer Drugs, with price, sales, revenue and global market share of Oncology & Cancer Drugs from 2019 to 2024.
Chapter 3, the Oncology & Cancer Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oncology & Cancer Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Oncology & Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oncology & Cancer Drugs.
Chapter 14 and 15, to describe Oncology & Cancer Drugs sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Oncology & Cancer Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oncology & Cancer Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Chemotherapy
1.3.3 Targeted Therapy
1.3.4 Immunotherapy (Biologic Therapy)
1.3.5 Hormonal Therapy
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Oncology & Cancer Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Blood Cancer
1.4.3 Breast Cancer
1.4.4 Gastrointestinal Cancer
1.4.5 Prostate Cancer
1.4.6 Respiratory/Lung Cancer
1.4.7 Others
1.5 Global Oncology & Cancer Drugs Market Size & Forecast
1.5.1 Global Oncology & Cancer Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Oncology & Cancer Drugs Sales Quantity (2019-2030)
1.5.3 Global Oncology & Cancer Drugs Average Price (2019-2030)
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Oncology & Cancer Drugs Product and Services
2.1.4 Roche Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments/Updates
2.2 Celgene
2.2.1 Celgene Details
2.2.2 Celgene Major Business
2.2.3 Celgene Oncology & Cancer Drugs Product and Services
2.2.4 Celgene Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Celgene Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Oncology & Cancer Drugs Product and Services
2.3.4 Novartis Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments/Updates
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Oncology & Cancer Drugs Product and Services
2.4.4 Bristol-Myers Squibb Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bristol-Myers Squibb Recent Developments/Updates
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Oncology & Cancer Drugs Product and Services
2.5.4 Johnson & Johnson Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Johnson & Johnson Recent Developments/Updates
2.6 Merck & Co.
2.6.1 Merck & Co. Details
2.6.2 Merck & Co. Major Business
2.6.3 Merck & Co. Oncology & Cancer Drugs Product and Services
2.6.4 Merck & Co. Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Merck & Co. Recent Developments/Updates
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Oncology & Cancer Drugs Product and Services
2.7.4 AstraZeneca Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 AstraZeneca Recent Developments/Updates
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Oncology & Cancer Drugs Product and Services
2.8.4 Pfizer Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Pfizer Recent Developments/Updates
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business
2.9.3 Amgen Oncology & Cancer Drugs Product and Services
2.9.4 Amgen Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Amgen Recent Developments/Updates
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business
2.10.3 Eli Lilly Oncology & Cancer Drugs Product and Services
2.10.4 Eli Lilly Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Eli Lilly Recent Developments/Updates
2.11 AbbVie
2.11.1 AbbVie Details
2.11.2 AbbVie Major Business
2.11.3 AbbVie Oncology & Cancer Drugs Product and Services
2.11.4 AbbVie Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 AbbVie Recent Developments/Updates
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business
2.12.3 Takeda Oncology & Cancer Drugs Product and Services
2.12.4 Takeda Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Takeda Recent Developments/Updates
2.13 Astellas
2.13.1 Astellas Details
2.13.2 Astellas Major Business
2.13.3 Astellas Oncology & Cancer Drugs Product and Services
2.13.4 Astellas Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Astellas Recent Developments/Updates
2.14 Ipsen
2.14.1 Ipsen Details
2.14.2 Ipsen Major Business
2.14.3 Ipsen Oncology & Cancer Drugs Product and Services
2.14.4 Ipsen Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Ipsen Recent Developments/Updates
2.15 Sanofi
2.15.1 Sanofi Details
2.15.2 Sanofi Major Business
2.15.3 Sanofi Oncology & Cancer Drugs Product and Services
2.15.4 Sanofi Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Sanofi Recent Developments/Updates
2.16 Bayer
2.16.1 Bayer Details
2.16.2 Bayer Major Business
2.16.3 Bayer Oncology & Cancer Drugs Product and Services
2.16.4 Bayer Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Bayer Recent Developments/Updates
2.17 Biogen Idec
2.17.1 Biogen Idec Details
2.17.2 Biogen Idec Major Business
2.17.3 Biogen Idec Oncology & Cancer Drugs Product and Services
2.17.4 Biogen Idec Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Biogen Idec Recent Developments/Updates
2.18 Teva
2.18.1 Teva Details
2.18.2 Teva Major Business
2.18.3 Teva Oncology & Cancer Drugs Product and Services
2.18.4 Teva Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Teva Recent Developments/Updates
2.19 Otsuka
2.19.1 Otsuka Details
2.19.2 Otsuka Major Business
2.19.3 Otsuka Oncology & Cancer Drugs Product and Services
2.19.4 Otsuka Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Otsuka Recent Developments/Updates
2.20 Eisai
2.20.1 Eisai Details
2.20.2 Eisai Major Business
2.20.3 Eisai Oncology & Cancer Drugs Product and Services
2.20.4 Eisai Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Eisai Recent Developments/Updates
2.21 Merck KGaA
2.21.1 Merck KGaA Details
2.21.2 Merck KGaA Major Business
2.21.3 Merck KGaA Oncology & Cancer Drugs Product and Services
2.21.4 Merck KGaA Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Merck KGaA Recent Developments/Updates
2.22 Gilead Sciences
2.22.1 Gilead Sciences Details
2.22.2 Gilead Sciences Major Business
2.22.3 Gilead Sciences Oncology & Cancer Drugs Product and Services
2.22.4 Gilead Sciences Oncology & Cancer Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Gilead Sciences Recent Developments/Updates
3.1 Global Oncology & Cancer Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Oncology & Cancer Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Oncology & Cancer Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Oncology & Cancer Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Oncology & Cancer Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Oncology & Cancer Drugs Manufacturer Market Share in 2023
3.5 Oncology & Cancer Drugs Market: Overall Company Footprint Analysis
3.5.1 Oncology & Cancer Drugs Market: Region Footprint
3.5.2 Oncology & Cancer Drugs Market: Company Product Type Footprint
3.5.3 Oncology & Cancer Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Oncology & Cancer Drugs Market Size by Region
4.1.1 Global Oncology & Cancer Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Oncology & Cancer Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Oncology & Cancer Drugs Average Price by Region (2019-2030)
4.2 North America Oncology & Cancer Drugs Consumption Value (2019-2030)
4.3 Europe Oncology & Cancer Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Oncology & Cancer Drugs Consumption Value (2019-2030)
4.5 South America Oncology & Cancer Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Oncology & Cancer Drugs Consumption Value (2019-2030)
5.1 Global Oncology & Cancer Drugs Sales Quantity by Type (2019-2030)
5.2 Global Oncology & Cancer Drugs Consumption Value by Type (2019-2030)
5.3 Global Oncology & Cancer Drugs Average Price by Type (2019-2030)
6.1 Global Oncology & Cancer Drugs Sales Quantity by Application (2019-2030)
6.2 Global Oncology & Cancer Drugs Consumption Value by Application (2019-2030)
6.3 Global Oncology & Cancer Drugs Average Price by Application (2019-2030)
7.1 North America Oncology & Cancer Drugs Sales Quantity by Type (2019-2030)
7.2 North America Oncology & Cancer Drugs Sales Quantity by Application (2019-2030)
7.3 North America Oncology & Cancer Drugs Market Size by Country
7.3.1 North America Oncology & Cancer Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Oncology & Cancer Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Oncology & Cancer Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Oncology & Cancer Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Oncology & Cancer Drugs Market Size by Country
8.3.1 Europe Oncology & Cancer Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Oncology & Cancer Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Oncology & Cancer Drugs Market Size by Region
9.3.1 Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Oncology & Cancer Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Oncology & Cancer Drugs Sales Quantity by Type (2019-2030)
10.2 South America Oncology & Cancer Drugs Sales Quantity by Application (2019-2030)
10.3 South America Oncology & Cancer Drugs Market Size by Country
10.3.1 South America Oncology & Cancer Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Oncology & Cancer Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Oncology & Cancer Drugs Market Size by Country
11.3.1 Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Oncology & Cancer Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Oncology & Cancer Drugs Market Drivers
12.2 Oncology & Cancer Drugs Market Restraints
12.3 Oncology & Cancer Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Oncology & Cancer Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oncology & Cancer Drugs
13.3 Oncology & Cancer Drugs Production Process
13.4 Oncology & Cancer Drugs Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oncology & Cancer Drugs Typical Distributors
14.3 Oncology & Cancer Drugs Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Oncology & Cancer Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Oncology & Cancer Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Oncology & Cancer Drugs Product and Services
Table 6. Roche Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Roche Recent Developments/Updates
Table 8. Celgene Basic Information, Manufacturing Base and Competitors
Table 9. Celgene Major Business
Table 10. Celgene Oncology & Cancer Drugs Product and Services
Table 11. Celgene Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Celgene Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis Oncology & Cancer Drugs Product and Services
Table 16. Novartis Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Novartis Recent Developments/Updates
Table 18. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 19. Bristol-Myers Squibb Major Business
Table 20. Bristol-Myers Squibb Oncology & Cancer Drugs Product and Services
Table 21. Bristol-Myers Squibb Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Bristol-Myers Squibb Recent Developments/Updates
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Oncology & Cancer Drugs Product and Services
Table 26. Johnson & Johnson Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Johnson & Johnson Recent Developments/Updates
Table 28. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 29. Merck & Co. Major Business
Table 30. Merck & Co. Oncology & Cancer Drugs Product and Services
Table 31. Merck & Co. Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Merck & Co. Recent Developments/Updates
Table 33. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 34. AstraZeneca Major Business
Table 35. AstraZeneca Oncology & Cancer Drugs Product and Services
Table 36. AstraZeneca Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. AstraZeneca Recent Developments/Updates
Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Oncology & Cancer Drugs Product and Services
Table 41. Pfizer Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Pfizer Recent Developments/Updates
Table 43. Amgen Basic Information, Manufacturing Base and Competitors
Table 44. Amgen Major Business
Table 45. Amgen Oncology & Cancer Drugs Product and Services
Table 46. Amgen Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Amgen Recent Developments/Updates
Table 48. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 49. Eli Lilly Major Business
Table 50. Eli Lilly Oncology & Cancer Drugs Product and Services
Table 51. Eli Lilly Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Eli Lilly Recent Developments/Updates
Table 53. AbbVie Basic Information, Manufacturing Base and Competitors
Table 54. AbbVie Major Business
Table 55. AbbVie Oncology & Cancer Drugs Product and Services
Table 56. AbbVie Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. AbbVie Recent Developments/Updates
Table 58. Takeda Basic Information, Manufacturing Base and Competitors
Table 59. Takeda Major Business
Table 60. Takeda Oncology & Cancer Drugs Product and Services
Table 61. Takeda Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Takeda Recent Developments/Updates
Table 63. Astellas Basic Information, Manufacturing Base and Competitors
Table 64. Astellas Major Business
Table 65. Astellas Oncology & Cancer Drugs Product and Services
Table 66. Astellas Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Astellas Recent Developments/Updates
Table 68. Ipsen Basic Information, Manufacturing Base and Competitors
Table 69. Ipsen Major Business
Table 70. Ipsen Oncology & Cancer Drugs Product and Services
Table 71. Ipsen Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Ipsen Recent Developments/Updates
Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Major Business
Table 75. Sanofi Oncology & Cancer Drugs Product and Services
Table 76. Sanofi Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Sanofi Recent Developments/Updates
Table 78. Bayer Basic Information, Manufacturing Base and Competitors
Table 79. Bayer Major Business
Table 80. Bayer Oncology & Cancer Drugs Product and Services
Table 81. Bayer Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Bayer Recent Developments/Updates
Table 83. Biogen Idec Basic Information, Manufacturing Base and Competitors
Table 84. Biogen Idec Major Business
Table 85. Biogen Idec Oncology & Cancer Drugs Product and Services
Table 86. Biogen Idec Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Biogen Idec Recent Developments/Updates
Table 88. Teva Basic Information, Manufacturing Base and Competitors
Table 89. Teva Major Business
Table 90. Teva Oncology & Cancer Drugs Product and Services
Table 91. Teva Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Teva Recent Developments/Updates
Table 93. Otsuka Basic Information, Manufacturing Base and Competitors
Table 94. Otsuka Major Business
Table 95. Otsuka Oncology & Cancer Drugs Product and Services
Table 96. Otsuka Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Otsuka Recent Developments/Updates
Table 98. Eisai Basic Information, Manufacturing Base and Competitors
Table 99. Eisai Major Business
Table 100. Eisai Oncology & Cancer Drugs Product and Services
Table 101. Eisai Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Eisai Recent Developments/Updates
Table 103. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 104. Merck KGaA Major Business
Table 105. Merck KGaA Oncology & Cancer Drugs Product and Services
Table 106. Merck KGaA Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Merck KGaA Recent Developments/Updates
Table 108. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 109. Gilead Sciences Major Business
Table 110. Gilead Sciences Oncology & Cancer Drugs Product and Services
Table 111. Gilead Sciences Oncology & Cancer Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. Gilead Sciences Recent Developments/Updates
Table 113. Global Oncology & Cancer Drugs Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 114. Global Oncology & Cancer Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 115. Global Oncology & Cancer Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 116. Market Position of Manufacturers in Oncology & Cancer Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 117. Head Office and Oncology & Cancer Drugs Production Site of Key Manufacturer
Table 118. Oncology & Cancer Drugs Market: Company Product Type Footprint
Table 119. Oncology & Cancer Drugs Market: Company Product Application Footprint
Table 120. Oncology & Cancer Drugs New Market Entrants and Barriers to Market Entry
Table 121. Oncology & Cancer Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 122. Global Oncology & Cancer Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 123. Global Oncology & Cancer Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 124. Global Oncology & Cancer Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 125. Global Oncology & Cancer Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 126. Global Oncology & Cancer Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 127. Global Oncology & Cancer Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 128. Global Oncology & Cancer Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 129. Global Oncology & Cancer Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 130. Global Oncology & Cancer Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 131. Global Oncology & Cancer Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 132. Global Oncology & Cancer Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 133. Global Oncology & Cancer Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 134. Global Oncology & Cancer Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 135. Global Oncology & Cancer Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 136. Global Oncology & Cancer Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 137. Global Oncology & Cancer Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 138. Global Oncology & Cancer Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 139. Global Oncology & Cancer Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 140. North America Oncology & Cancer Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 141. North America Oncology & Cancer Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 142. North America Oncology & Cancer Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 143. North America Oncology & Cancer Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 144. North America Oncology & Cancer Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 145. North America Oncology & Cancer Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 146. North America Oncology & Cancer Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 147. North America Oncology & Cancer Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 148. Europe Oncology & Cancer Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 149. Europe Oncology & Cancer Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 150. Europe Oncology & Cancer Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 151. Europe Oncology & Cancer Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 152. Europe Oncology & Cancer Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 153. Europe Oncology & Cancer Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 154. Europe Oncology & Cancer Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 155. Europe Oncology & Cancer Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 156. Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 157. Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 158. Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 159. Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 160. Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 161. Asia-Pacific Oncology & Cancer Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 162. Asia-Pacific Oncology & Cancer Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 163. Asia-Pacific Oncology & Cancer Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 164. South America Oncology & Cancer Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 165. South America Oncology & Cancer Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 166. South America Oncology & Cancer Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 167. South America Oncology & Cancer Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 168. South America Oncology & Cancer Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 169. South America Oncology & Cancer Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 170. South America Oncology & Cancer Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 171. South America Oncology & Cancer Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 172. Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 173. Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 174. Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 175. Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 176. Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 177. Middle East & Africa Oncology & Cancer Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 178. Middle East & Africa Oncology & Cancer Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 179. Middle East & Africa Oncology & Cancer Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 180. Oncology & Cancer Drugs Raw Material
Table 181. Key Manufacturers of Oncology & Cancer Drugs Raw Materials
Table 182. Oncology & Cancer Drugs Typical Distributors
Table 183. Oncology & Cancer Drugs Typical Customers
List of Figures
Figure 1. Oncology & Cancer Drugs Picture
Figure 2. Global Oncology & Cancer Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Oncology & Cancer Drugs Consumption Value Market Share by Type in 2023
Figure 4. Chemotherapy Examples
Figure 5. Targeted Therapy Examples
Figure 6. Immunotherapy (Biologic Therapy) Examples
Figure 7. Hormonal Therapy Examples
Figure 8. Others Examples
Figure 9. Global Oncology & Cancer Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Oncology & Cancer Drugs Consumption Value Market Share by Application in 2023
Figure 11. Blood Cancer Examples
Figure 12. Breast Cancer Examples
Figure 13. Gastrointestinal Cancer Examples
Figure 14. Prostate Cancer Examples
Figure 15. Respiratory/Lung Cancer Examples
Figure 16. Others Examples
Figure 17. Global Oncology & Cancer Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Oncology & Cancer Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Oncology & Cancer Drugs Sales Quantity (2019-2030) & (K Units)
Figure 20. Global Oncology & Cancer Drugs Average Price (2019-2030) & (US$/Unit)
Figure 21. Global Oncology & Cancer Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 22. Global Oncology & Cancer Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 23. Producer Shipments of Oncology & Cancer Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 24. Top 3 Oncology & Cancer Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Top 6 Oncology & Cancer Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 26. Global Oncology & Cancer Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 27. Global Oncology & Cancer Drugs Consumption Value Market Share by Region (2019-2030)
Figure 28. North America Oncology & Cancer Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Europe Oncology & Cancer Drugs Consumption Value (2019-2030) & (USD Million)
Figure 30. Asia-Pacific Oncology & Cancer Drugs Consumption Value (2019-2030) & (USD Million)
Figure 31. South America Oncology & Cancer Drugs Consumption Value (2019-2030) & (USD Million)
Figure 32. Middle East & Africa Oncology & Cancer Drugs Consumption Value (2019-2030) & (USD Million)
Figure 33. Global Oncology & Cancer Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 34. Global Oncology & Cancer Drugs Consumption Value Market Share by Type (2019-2030)
Figure 35. Global Oncology & Cancer Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 36. Global Oncology & Cancer Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 37. Global Oncology & Cancer Drugs Consumption Value Market Share by Application (2019-2030)
Figure 38. Global Oncology & Cancer Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 39. North America Oncology & Cancer Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 40. North America Oncology & Cancer Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 41. North America Oncology & Cancer Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 42. North America Oncology & Cancer Drugs Consumption Value Market Share by Country (2019-2030)
Figure 43. United States Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Canada Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Mexico Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Europe Oncology & Cancer Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 47. Europe Oncology & Cancer Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 48. Europe Oncology & Cancer Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 49. Europe Oncology & Cancer Drugs Consumption Value Market Share by Country (2019-2030)
Figure 50. Germany Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. France Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. United Kingdom Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Russia Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Italy Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Asia-Pacific Oncology & Cancer Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 56. Asia-Pacific Oncology & Cancer Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 57. Asia-Pacific Oncology & Cancer Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 58. Asia-Pacific Oncology & Cancer Drugs Consumption Value Market Share by Region (2019-2030)
Figure 59. China Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Japan Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Korea Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. India Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Southeast Asia Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Australia Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. South America Oncology & Cancer Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 66. South America Oncology & Cancer Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 67. South America Oncology & Cancer Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 68. South America Oncology & Cancer Drugs Consumption Value Market Share by Country (2019-2030)
Figure 69. Brazil Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Argentina Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Middle East & Africa Oncology & Cancer Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 72. Middle East & Africa Oncology & Cancer Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 73. Middle East & Africa Oncology & Cancer Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 74. Middle East & Africa Oncology & Cancer Drugs Consumption Value Market Share by Region (2019-2030)
Figure 75. Turkey Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Egypt Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Saudi Arabia Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. South Africa Oncology & Cancer Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. Oncology & Cancer Drugs Market Drivers
Figure 80. Oncology & Cancer Drugs Market Restraints
Figure 81. Oncology & Cancer Drugs Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Oncology & Cancer Drugs in 2023
Figure 84. Manufacturing Process Analysis of Oncology & Cancer Drugs
Figure 85. Oncology & Cancer Drugs Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Roche Celgene Novartis Bristol-Myers Squibb Johnson & Johnson Merck & Co. AstraZeneca Pfizer Amgen Eli Lilly AbbVie Takeda Astellas Ipsen Sanofi Bayer Biogen Idec Teva Otsuka Eisai Merck KGaA Gilead Sciences
Related Reports
10 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
